Health Catalyst (HCAT) Cash from Financing Activities (2018 - 2026)

Health Catalyst has reported Cash from Financing Activities for 9 years, with the latest figure at -$4000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Financing Activities rose 99.92% year-over-year to -$4000.0; the trailing twelve-month figure through Mar 2026 stood at -$231.1 million (down 258.08% YoY), and the FY2025 full-year result was -$235.8 million, down 255.38% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at -$4000.0, up from -$434000.0 in the prior quarter.
• The five-year high for Cash from Financing Activities was $112.5 million in Q3 2024, with the low at -$230.1 million in Q2 2025.
• Historically, Cash from Financing Activities has averaged -$4.9 million across 5 years, with a median of $637000.0 in 2022.
• Annual changes were most pronounced in 2024 — Cash from Financing Activities jumped 10716.83% — and 2025, when it tumbled 33065.47%.
• Health Catalyst's Cash from Financing Activities stood at $637000.0 in 2022, then tumbled by 37.99% to $395000.0 in 2023, then surged by 9441.77% to $37.7 million in 2024, then plunged by 101.15% to -$434000.0 in 2025, then surged by 99.08% to -$4000.0 in 2026.
• The last three Cash from Financing Activities figures came in at -$4000.0 (Q1 2026), -$434000.0 (Q4 2025), and -$537000.0 (Q3 2025), per Business Quant data.